Discover open access scientific publications

Search, annotate, share and cite publications

Publications by J. Rubio-Martínez

MA10.01 Antibiotic Use and PD-1 Inhibitors: Shorter Survival in Lung Cancer, Especially When Given Intravenously. Type of Infection Also Matters

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.01-69 Validation of the Lung Immune Prognostic Index (LIPI): Useful to Identify Resistance to PD-1 Checkpoint Inhibitors in Pretreated Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

Related publications

P1.07-008 Microbiome & Immunotherapy: Antibiotic Use Is Associated With Inferior Survival for Lung Cancer Patients Receiving PD-1 Inhibitors

Journal of Thoracic Oncology

Respiratory Medicine

English

Design of PD-L1 Inhibitors for Lung Cancer

English

Immune Reprogramming via PD-1 Inhibition Enhances Early-Stage Lung Cancer Survival

English

P3.01-18 Comparison of PD-L1 Immunohistochemical Assays and Clinical Response to Anti PD-1 Checkpoint Inhibitors in Patients With Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

Immunotherapies Based on PD-1/PD-L1 Pathway Inhibitors in Ovarian Cancer Treatment

Clinical and Experimental Immunology

English

Doses of Aminophylline Given Intravenously in Casualty.

English

Real-World Evidenceand Clinical Observations of the Treatment of Advanced Non-Small Cell Lung Cancer With PD-1/PD-L1 Inhibitors

Scientific Reports

Multidisciplinary

English

P2.01-82 Neutrophil-To-Lymphocyte Ratio Complements the Prognostic Ability of PD-L1 in Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors

Journal of Thoracic Oncology

Respiratory Medicine

English

Comparison of the Toxicity Profile of PD-1 Versus PD-L1 Inhibitors in Non-Small Cell Lung Cancer: A Systematic Analysis of the Literature

Cancer Research

English